...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: RBC unregistered to registered account

narmac, if you go back to the notes of Don's comments from the Sept 12th 2018 AGM Don stated something to the effect - to paraphrase - If I had put Zenith on an exchange probably most of you would have sold half your shares right away. I didn't go for a listing because we needed something to provide value. We now have it but I can't talk about it yet.

I found Don's statement very condecending to shareholders but probably true.

Subsequently we heard about the TNBC trial with Pfizer.

There was also supposed to be a financing from China and I don't know if this happened. I should have got back to the notes but I just don't have time these days.

Final point is that I felt back in 2013 when spinco was created that it was pure geneous and I feel it now more then ever as we near the end of BoM at RVX.

I do hope we'll see a CVR or 2 or 3 at Zenith.

Cheers

Toinv

Share
New Message
Please login to post a reply